Association of Combined Healthy Lifestyles With Cardiovascular Disease and Mortality Among Patients With Diabetes: An International Multi-Cohort Study
Dr Yan-Bo Zhang finds adherence to a healthy lifestyle is associated with lower risk of CV disease and premature death among patients with diabetes.
ARNI in HFrEF Patients With Advanced CKD
Dr. Chien-Yi Hsu finds angiotensin receptor-neprilysin inhibitor users have a significantly lower risks of 1-year all-cause mortality.
Hematological Malignancies in Elderly Patients With Ankylosing Spondylitis
Dr Michael Ward finds older adults with ankylosing spondylitis are at a higher risk for non-Hodgkin lymphoma, chronic lymphocytic leukemia, and multiple myeloma.
A Review of Medical Management of Erythromelalgia
Dr Mark Dennis P. Davis provides patients and clinicians with management strategies for treating erythromelalgia.
Left Internal Mammary Artery as an Endocrine Organ
Dr Ilya Shadrin notes understanding the protective secretory profile germane to the vascular cells comprising the left internal mammary artery in relation to other surgical conduits serves to unlock new opportunities in the development of platforms to reverse coronary artery disease.
Revascularization in Patients With Non-ST Elevation MI and Advanced CKD
Dr. Fu-Chih Hsiao finds revascularization was associated with a lower risk of all-cause mortality in NSTEMI patients with severe chronic kidney disease.
a More Patient Attitude Toward a Single Unprovoked Seizure
Dr Anteneh Feyissa differentiates between true first-time seizures that meet or don’t meet the diagnosis of epilepsy preventing unnecessary use of antiseizure medications and lifestyle limitations associated with the diagnosis of epilepsy.
Organization-Wide Approaches to Foster Effective Unit-Level Efforts to Improve Clinician Well-Being
Dr Tait Shanafelt offers guidance for institutions to foster unit-level wellness plans.
Clinical Outcomes After Heart Failure Hospitalizations in COVID-19
Dr Mohammed Yousufuddin and Ms Jewell Doss find lower rates of hospitalizations and increased rates of 30-day mortality for patients with heart failure during COVID-19.
